Spreading the Word About Thrombosis
After fracturing her ankle and getting a cast, South African athlete Marie-Victoire Cumming began feeling extreme discomfort in her leg. What she didn't know was that she had a potentially life-threatening condition called deep vein thrombosis.
Menopause Rx: The Heart of the Matter
The use of hormones during menopause was once thought to protect against heart disease, but that may not be the case.
Stop Blood Clots, Prevent Future Strokes
Ischemic stroke is the third leading cause of death in the United States. Preventing future ischemic strokes means preventing more blood clots from forming.
An Aspirin a Day After Blood Clots
A common treatment after having a blood clot is taking blood thinner medication. But many doctors will eventually take patients off medication when it's no longer necessary. Then what?
When the Body Turns on Itself
Some people's immune systems produce antibodies that fight parts of their own bodies. These aren’t always a big deal. But sometimes they can contribute to stroke or miscarriage risk.
Newer Blood Thinner Gaining Affirmation
Patients with atrial fibrillation, a common heart arrhythmia, have a higher risk of experiencing a stroke or blood clots. Warfarin (Coumadin) has long been the gold standard in treatment. That could be changing.
FDA Delays Blood Thinner Eliquis Again
United States Food and Drug Administration officials today delayed approval of Eliquis ( apixaban ) to prevent stroke or systemic embolism in patients with a common heart arrhythmia for the second time.
Hearts Love Aspirin and Warfarin
Heart failure patients often take medication to lower their risk of stroke, hemorrhage or dying. A common choice is warfarin (Coumadin), though a large clinical trial has found that cheaper over-the-counter aspirin may be just as effective.
Risk High During Temporary Anticoagulant Halts
Patients with certain types of atrial fibrillation, a common heart arrhythmia, are at a high risk of stroke and blood clots if they temporarily stop their blood thinning medication before surgery or permanently because of side effects.
Apixaban Fails to Reduce Blood Clots
An experimental drug designed to aid severely ill patients after hospitalization is not more effective than standard treatments for reducing the risk of blood clots, a study has confirmed.